Literature DB >> 17565284

Investigating ADHD treatment trajectories: listening to families' stories about medication use.

Laurel K Leslie1, Dena Plemmons, Amy R Monn, Lawrence A Palinkas.   

Abstract

OBJECTIVE: Policymakers, federal agencies, and researchers have called for more in-depth investigation of contextual mechanisms that may explain differences in medication use among youths with attention-deficit/hyperactivity disorder (ADHD).
METHOD: We conducted qualitative interviews with 28 families from varied socioeconomic and racial/ethnic and linguistic backgrounds regarding diagnostic and treatment trajectories for their children with symptoms consistent with ADHD, with a particular focus on whether and how medication use became a part of the trajectory.
RESULTS: Four longitudinal patterns of help-seeking trajectories emerged: (1) a pattern characterized by delay to diagnosis, common among youths with complicated clinical and/or environmental pictures or primarily inattentive ADHD symptoms; (2) an initial nonmedication treatment pattern in which parents at first chose to use other modalities of treatment; (3) a reluctant receipt of an ADHD diagnosis and/or treatment pattern, mainly seen among the low-income, Spanish-speaking families; and (4) a rapid engagement in medication use pattern, characterized by directed movement to and maintenance of medication use. These patterns resulted from a dynamic interplay of explanatory models regarding the cause, course, and cure of a child's problems; the influence of extended social networks; and factors previously examined in medical utilization models. Additional themes included (1) parents' need for more information about ADHD, (2) families' desire for additional mental health and school services making medications less necessary, and (3) the importance of cultural sensitivity and a longitudinal relationship between the caregiver and clinician to enhance communication between families and clinicians.
CONCLUSIONS: These findings deserve further study in a larger, more diverse sample.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17565284     DOI: 10.1097/DBP.0b013e3180324d9a

Source DB:  PubMed          Journal:  J Dev Behav Pediatr        ISSN: 0196-206X            Impact factor:   2.225


  34 in total

1.  Using Best-Worst Scaling to Measure Caregiver Preferences for Managing their Child's ADHD: A Pilot Study.

Authors:  Susan dosReis; Xinyi Ng; Emily Frosch; Gloria Reeves; Charles Cunningham; John F P Bridges
Journal:  Patient       Date:  2015-10       Impact factor: 3.883

2.  Adolescents' commitment to continuing psychotropic medication: a preliminary investigation of considerations, contradictions, and correlates.

Authors:  Tally Moses
Journal:  Child Psychiatry Hum Dev       Date:  2011-02

3.  The Role of Parental Knowledge and Attitudes about ADHD and Perceptions of Treatment Response in the Treatment Utilization of Families of Children with ADHD.

Authors:  Rosanna Breaux; Daniel A Waschbusch; Rebecca Marshall; Hugh Humphrey; William E Pelham; James G Waxmonsky
Journal:  Evid Based Pract Child Adolesc Ment Health       Date:  2020-03-24

4.  A best-worst scaling experiment to prioritize caregiver concerns about ADHD medication for children.

Authors:  Melissa Ross; John F P Bridges; Xinyi Ng; Lauren D Wagner; Emily Frosch; Gloria Reeves; Susan dosReis
Journal:  Psychiatr Serv       Date:  2014-11-17       Impact factor: 3.084

5.  Predictors of Medication Continuity in Children With ADHD.

Authors:  William B Brinkman; Heidi Sucharew; Jessica Hartl Majcher; Jeffery N Epstein
Journal:  Pediatrics       Date:  2018-06       Impact factor: 7.124

6.  Parent and Family Processes Related to ADHD Management in Ethnically Diverse Youth.

Authors:  Cynthia P Paidipati; Bridgette Brawner; Ricardo Eiraldi; Janet A Deatrick
Journal:  J Am Psychiatr Nurses Assoc       Date:  2017-01-11       Impact factor: 2.385

7.  Reasons Why Children and Adolescents With Attention-Deficit/Hyperactivity Disorder Stop and Restart Taking Medicine.

Authors:  William B Brinkman; John O Simon; Jeffery N Epstein
Journal:  Acad Pediatr       Date:  2017-09-12       Impact factor: 3.107

8.  A Latent Class Analysis to Identify Variation in Caregivers' Preferences for their Child's Attention-Deficit/Hyperactivity Disorder Treatment: Do Stated Preferences Match Current Treatment?

Authors:  Xinyi Ng; John F P Bridges; Melissa M Ross; Emily Frosch; Gloria Reeves; Charles E Cunningham; Susan dosReis
Journal:  Patient       Date:  2017-04       Impact factor: 3.883

9.  Development of an instrument to measure parents' preferences and goals for the treatment of attention deficit-hyperactivity disorder.

Authors:  Alexander G Fiks; Stephanie Mayne; Cayce C Hughes; Elena Debartolo; Carina Behrens; James P Guevara; Thomas Power
Journal:  Acad Pediatr       Date:  2012-06-28       Impact factor: 3.107

10.  The meaning of attention-deficit/hyperactivity disorder medication and parents' initiation and continuity of treatment for their child.

Authors:  Susan DosReis; Matthew P Mychailyszyn; Sara E Evans-Lacko; Alicia Beltran; Anne W Riley; Mary Anne Myers
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-08       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.